Related Experiment Video
Updated: Dec 25, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
BRMS1: a multifunctional signaling molecule in metastasis
Rosalyn C Zimmermann1, Danny R Welch2,3
1Department of Cancer Biology, The Kansas University Medical Center, 3901 Rainbow Blvd., Kansas City, KS, 66160, USA.
Abstract:
Despite high mortality rates, molecular understanding of metastasis remains limited. It can be regulated by both pro- and anti-metastasis genes. The metastasis suppressor, breast cancer metastasis suppressor 1 (BRMS1), has been positively correlated with patient outcomes, but molecular functions are still being characterized. BRMS1 has been implicated in focal adhesion kinase (FAK), epidermal growth factor receptor (EGFR), and NF-κB signaling pathways. We review evidence that BRMS1 regulates these vast signaling pathways through chromatin remodeling as a member of mSin3 histone deacetylase complexes.
Insights
Breast cancer metastasis suppressor 1 (BRMS1) may regulate cancer cell spread by remodeling chromatin. This metastasis suppressor gene is linked to key signaling pathways, offering new therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Metastasis, a major cause of cancer mortality, has a limited molecular understanding.
- Breast cancer metastasis suppressor 1 (BRMS1) is an anti-metastasis gene correlated with improved patient outcomes.
- BRMS1's precise molecular functions and its role in signaling pathways require further elucidation.
Purpose of the Study:
- To review the molecular functions of BRMS1 in cancer metastasis.
- To explore BRMS1's regulation of focal adhesion kinase (FAK), epidermal growth factor receptor (EGFR), and NF-κB signaling.
- To understand BRMS1's mechanism of action as a component of mSin3 histone deacetylase complexes.
Main Methods:
- Literature review of studies investigating BRMS1 function.
- Analysis of evidence linking BRMS1 to specific signaling pathways.
- Examination of BRMS1's role in chromatin remodeling.
Main Results:
- BRMS1 is implicated in regulating FAK, EGFR, and NF-κB signaling pathways.
- BRMS1 functions as a metastasis suppressor, influencing cancer cell behavior.
- BRMS1's activity is associated with chromatin remodeling via mSin3 histone deacetylase complexes.
Conclusions:
- BRMS1 plays a critical role in suppressing cancer metastasis.
- BRMS1 likely exerts its function by modulating key signaling pathways through chromatin remodeling.
- Further characterization of BRMS1 offers potential for novel anti-metastasis therapeutic strategies.
More Related Videos
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Ras Gene
Ras is a...

